Lexicon Pharma (LXRX) Tops Q2 EPS by 1c
Tweet
Share
E-mail
Get Alerts LXRX Hot Sheet
Price: $2.05 +0.49%
Revenue Growth %: -78.9%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: -78.9%
Financial Fact:
Interest expense: -1.65M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Lexicon Pharma (NASDAQ: LXRX) reported Q2 EPS of ($0.17), $0.01 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $1.65 million versus the consensus estimate of $3.44 million.
For earnings history and earnings-related data on Lexicon Pharma (LXRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Faraday Future unveils nine robot models, prices start at $9,990
- Trump announces security deal with Denmark on Greenland
- Axion Minerals plans flow-through private placement of up to $440K
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
